Chad W. Souvignier

Dr. Souvignier conducts the scientific and business analysis of early-stage biomedical investment opportunities for Research Corporation Technologies (RCT) and also manages a portfolio of projects and investments for RCT. His areas of focus at RCT include oncology, pain, central nervous system disorders, diabetes, and metabolic disease.

Chad received his M.B.A., Eller Graduate School of Management, and his Ph.D., Materials Science and Engineering, from the University of Arizona.